Member Info for Laura2022

This last post from you ( as you've spent 8/10 on PYC) is truly laughable

jaari888

Posted in: RENX

Posts: 91

Price: 9.50

No Opinion

RE: Very Bullish Vox Markets interview out12 Dec 2024 22:47

How long before Microsoft and Google enter into a bidding war for RENX

https://www.ft.com/content/c41b9dec-d823-466f-a880-d223e3c34e19

This obsession from jaari is worrying

11 posts PYC

7 FAB

4RENX (where he's gone silent probably due to £6mln+ losses and ceo salary of a extortionate $510k for delivering nothing

SCE 2 (again went quiet and SCE been losing £10mln a year and has no money)

More lies from jaari

"No revenue growth "

Yet the company states this for the year end June 2024

Company achieved record levels of contract awards, with more than £1.1m of new contracts signed during the financial year and a record level of contracted revenue (more than £500k) to be taken forward into the next financial year ending 30 June 2025. Additional revenue has also been contracted for the two years ended 2026 and 202

AND in the half year July 1st to Dec 2024 has won record revenues ever for a H1

You really are a desperate liar

Thanks MM

Really good summary

As for PYC I did some overview this morning if u wish to look

Happy Xmas

Good morning Moneymunch

I have been looking at several bio techs given the support both the labour and Trump gov are showing over last 2mths for life sciences

I will take a further look

In return, at £1.4mln a slightly similar company PYC is worth looking at

I will be taking some shares here as j like the look of GENF

With Pyc unique and cutting edge offerings a takeover valuation of x 10 earnings would mean a minimum of £10mln ( versus current £1.4)

https://www.dailymail.co.uk/money/markets/article-14211559/UK-faces-swarm-takeover-bids-new-year-One-three-AIM-stocks-risk-says-Investment-bank-Peel-Hunt.html

Michael Nicholson, head of mergers and acquisitions at Peel Hunt, added: ‘It seems certain 2025 will bring a major and sustained flow of UK takeovers.

‘Bid defence manuals are no longer an item to be left on the shelf. They ought to be front-of-mind for all boards.’

Stocks on London’s junior market AIM are particularly at risk of takeovers in 2025, the report said. Up to a third of small and mid-cap AIM businesses could be snapped up.

Well Duke

Some recent court cases of insider trading on the FCA website

This can easily be blocked so the main instigators may well need to buy a big chunk over the next few days

11. Recommendation

For the reasons noted above, the Directors consider that the Resolutions to be put to the meeting are in

the best interests of the Company and its Shareholders as a whole and therefore unanimously

recommend that you vote in favour of all of the Resolutions to be proposed at the General Meeting, as

the Directors intend to do in respect of their own aggregate holdings of 160,000 Ordinary Shares,

representing approximately 0.08 per cent. of the Company’s issued share capital as of the date of this

Circular.

Yours faithfully,

Jay Bhattacherjee

Non-Executive Chair

This can easily be blocked so the main instigators may well need to buy a big chunk over the next few days

https://www.sdxenergygroup.com/investors/significant-shareholders/

I've bought mine at 1.2-1.4p a month ago newgrange

Good , sound morally upstanding company Bell keeps

Dave Lenigas to jail over Pennpetro fraud?Today 08:33

By Tom Winnifrith

A shocking RNS today lays bare that shareholders in Pennpetro (PPP), especially those taking part in two 12p placings were deceived and misled as to the state of a company that now admits it is facing possible insolvency. It says it is investigating past directors, the fuzz should be investigating. Investors have bee defrauded, surely Lenigas should go to jail or, at the very least, never run a listed company again

Therfore

Feel free to compare/debate ...for example RENX against these facts

OR spend your time on your own stocks

£1.5mln cap

£600-700k cash ,no debt small losses

CE0 salary £72k is 1/4 of AIM average = modest and alligned

Record contracts won June 2023 to June 2024 £1mln

Record revenues going into end of H1 2024 of currently £800-900k (up to Dec 2024)

Only needs about £1.4mln FY revenues end of June 2025 to probably turn to profit

Working in niche A.I software development market worth $blns

New CEO made huge impact in just 9mths

Potentially very large bio statistic contracts to come (words of BOD at last presentation)

Access to EU and USA markets via NASDAQ partners

There are 100s of AIM stocks yet, after a 10yr hibernation you chose to re emerge trying and lying to talk about one company

You've posted 90% on here in 3mths and yet won't debate RENX which is your latest flame, having also.gone quiet on SCE FAB etc

Your motives.are obvious

Feel free to counter the points made last week regarding PYC

Jaari

Which recruitment "shenanigans "?

You've not answered questions on SCE RENX

Nor why your LSE account remained dormant for 10yrs

What a pathetic person

Just received

Here's part of it

Leadership Transition: We began the year with a major milestone as Dr. Peter Sargent stepped into the CEO role, bringing fresh focus to key initiatives like the launch of our Biostatistics offering and the enhancement of our Data Science and Bioinformatics capabilities.

Partnership Highlights: We had the pleasure of building new partnerships and deepening our existing partnerships with Numab Therapeutics AG, Cancer Research UK, and other leading biotech and pharma companies.

Expanding Expertise: In October, we officially launched our Biostatistics service while continuing to strengthen our ability to deliver tailored insights across drug development through expanded Data Science capabilities.

Engaging the Scientific Community: From ENA 2024 to BioEurope, we showcased exciting projects like our precision dosing tool and connected with industry leaders at major events.

Take a closer look at our 2024 highlights here.

The AIM shares de listed last 12mth have 4 things in common

1 large BOD insider holdings of 40%+ which means they've always pulled the strings

2 awful business model

3 excessive salaries

4 awful sectors

Good riddance so proper revenue generating and modest salary companies can thrive in niche markets

Access to capital: Tarak Ramzan, the majority shareholder with a 20.38% shareholding has proposed to provide a £1.0 million loan facility to provide additional liquidity headroom for working capital purposes

Stich ups easy when directors and associates hold 60% +

Company has received irrevocable undertakings to vote in favour of the Resolutions from all Directors and family members of Tarak Ramzan, the Group's founder, including Nusrat Ramzan, Kasim Akram, Omar Aziz, Haris Ramzan and Mussarat Ramzan. In addition the Company has received irrevocable undertakings from Tajveer Gill and Amraj Gill in respect of 21,600,000 Ordinary Shares in which they are legally and beneficially interested. In aggregate, the irrevocable undertakings to vote in favour of the Resolutions set out in the Circular represent approximately 66.74 per cent. of the Company's issued share capital.

Doesn't seem much stock around , will have ore freed up soon from PIP